These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 22710795

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin.
    Nam JO, Jeong HW, Lee BH, Park RW, Kim IS.
    Cancer Res; 2005 May 15; 65(10):4153-61. PubMed ID: 15899806
    [Abstract] [Full Text] [Related]

  • 3. Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effects.
    Son HN, Nam JO, Kim S, Kim IS.
    Biochim Biophys Acta; 2013 Oct 15; 1833(10):2378-88. PubMed ID: 23792174
    [Abstract] [Full Text] [Related]

  • 4. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
    Wang L, Zhang X, Pang N, Xiao L, Li Y, Chen N, Ren M, Deng X, Wu J.
    Cell Death Dis; 2015 Jun 25; 6(6):e1796. PubMed ID: 26111058
    [Abstract] [Full Text] [Related]

  • 5. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
    Montenegro CF, Salla-Pontes CL, Ribeiro JU, Machado AZ, Ramos RF, Figueiredo CC, Morandi V, Selistre-de-Araujo HS.
    Biochimie; 2012 Aug 25; 94(8):1812-20. PubMed ID: 22561350
    [Abstract] [Full Text] [Related]

  • 6. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH.
    Glycobiology; 2009 Mar 25; 19(3):229-39. PubMed ID: 18974200
    [Abstract] [Full Text] [Related]

  • 7. The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165.
    Traub S, Morgner J, Martino MM, Höning S, Swartz MA, Wickström SA, Hubbell JA, Eming SA.
    Biomaterials; 2013 Aug 25; 34(24):5958-68. PubMed ID: 23683723
    [Abstract] [Full Text] [Related]

  • 8. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2.
    Hall H, Hubbell JA.
    Microvasc Res; 2004 Nov 25; 68(3):169-78. PubMed ID: 15501236
    [Abstract] [Full Text] [Related]

  • 9. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW, Lien JC, Kuo SC, Huang TF.
    Carcinogenesis; 2012 May 25; 33(5):1022-30. PubMed ID: 22436611
    [Abstract] [Full Text] [Related]

  • 10. Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis.
    Li R, Luo M, Ren M, Chen N, Xia J, Deng X, Zeng M, Yan K, Luo T, Wu J.
    J Vasc Res; 2014 May 25; 51(2):110-7. PubMed ID: 24603119
    [Abstract] [Full Text] [Related]

  • 11. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
    Kinugasa M, Amano H, Satomi-Kobayashi S, Nakayama K, Miyata M, Kubo Y, Nagamatsu Y, Kurogane Y, Kureha F, Yamana S, Hirata K, Miyoshi J, Takai Y, Rikitake Y.
    Circ Res; 2012 Mar 02; 110(5):716-26. PubMed ID: 22282193
    [Abstract] [Full Text] [Related]

  • 12. Beta ig-h3 promotes renal proximal tubular epithelial cell adhesion, migration and proliferation through the interaction with alpha3beta1 integrin.
    Park SW, Bae JS, Kim KS, Park SH, Lee BH, Choi JY, Park JY, Ha SW, Kim YL, Kwon TH, Kim IS, Park RW.
    Exp Mol Med; 2004 Jun 30; 36(3):211-9. PubMed ID: 15272232
    [Abstract] [Full Text] [Related]

  • 13. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M, Bernard-Pierrot I, Delbé J, Hamma-Kourbali Y, Katsoris P, Barritault D, Papadimitriou E, Plouet J, Courty J.
    Oncogene; 2004 Mar 04; 23(9):1745-53. PubMed ID: 15001987
    [Abstract] [Full Text] [Related]

  • 14. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1.
    Zhang X, Groopman JE, Wang JF.
    J Cell Physiol; 2005 Jan 04; 202(1):205-14. PubMed ID: 15389531
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.
    Wu J, Strawn TL, Luo M, Wang L, Li R, Ren M, Xia J, Zhang Z, Ma W, Luo T, Lawrence DA, Fay WP.
    Arterioscler Thromb Vasc Biol; 2015 Jan 04; 35(1):111-20. PubMed ID: 25378411
    [Abstract] [Full Text] [Related]

  • 16. Variable effects of alpha v suppression on VEGFR-2 expression in endothelial cells of different vascular beds.
    Dardik R, Livnat T, Seligsohn U.
    Thromb Haemost; 2009 Nov 04; 102(5):975-82. PubMed ID: 19888537
    [Abstract] [Full Text] [Related]

  • 17. Recombinant RGD-disintegrin DisBa-01 blocks integrin αvβ3 and impairs VEGF signaling in endothelial cells.
    Danilucci TM, Santos PK, Pachane BC, Pisani GFD, Lino RLB, Casali BC, Altei WF, Selistre-de-Araujo HS.
    Cell Commun Signal; 2019 Mar 20; 17(1):27. PubMed ID: 30894182
    [Abstract] [Full Text] [Related]

  • 18. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.
    Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ, Bodary SC, Hodivala-Dilke KM.
    Cancer Res; 2004 Dec 01; 64(23):8643-50. PubMed ID: 15574772
    [Abstract] [Full Text] [Related]

  • 19. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
    O E, Kim HK, Hong SH, Kim CK, Hong YK, Joe YA.
    Oncol Rep; 2008 Sep 01; 20(3):631-6. PubMed ID: 18695916
    [Abstract] [Full Text] [Related]

  • 20. Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2.
    Patel NS, Mathura VS, Bachmeier C, Beaulieu-Abdelahad D, Laporte V, Weeks O, Mullan M, Paris D.
    J Neurochem; 2010 Jan 01; 112(1):66-76. PubMed ID: 19818105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.